Last checked at 9 Jul 2010 08:00
9 July 2010
Advanced Medical Solutions Group plc
("AMS" or "the Company")
Company Presentation
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, will today be hosting a research and development presentation for analysts and press.
No new material information will be disclosed during the presentation which will be available today to download from 13.00 on AMS's website: www.admedsol.com.
-ends -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Tel: +44 (0) 1606 545508
Mary Tavener, Finance Director
Chris Meredith, Chief Operating Officer
Tavistock Communications
John West / Chris Munden Tel: +44 (0) 20 7920 3150
Investec Bank plc
Gary Clarence / Daniel Adams Tel: +44 (0) 20 7597 5970
Notes to Editors:
AMS advanced woundcare products are based on an extensive range of technologies including alginates, silver alginates and hydrophilic polyurethane foam. These and other products pioneer the concept of moist wound healing, allowing wounds to heal faster and with less pain and scarring. They protect the wound, deal with tissue fluids and provide an optimal environment for healing to occur. Silver is widely recognised as a safe and effective broad-spectrum anti-microbial agent for infection control.
AMS wound closure and sealants products are based on cyanoacrylate adhesive technology developed for medical applications. Tissue adhesives offer significant benefits over conventional ways of closing wounds following trauma or surgical incision. They are simple to use, non-invasive, help to reduce the risk of infection, minimise trauma to the patient and provide good clinical and cosmetic outcomes. The technology is also ideally suited to protecting skin from breakdown or for use as a skin sealant to help prevent infection of surgical sites.